Skip to main content
. Author manuscript; available in PMC: 2013 Mar 6.
Published in final edited form as: Transplantation. 2010 Apr 15;89(7):838–844. doi: 10.1097/TP.0b013e3181ca56f8

Figure 1.

Figure 1

Humoral and cellular responses to Influenza vaccination. 1A: Humoral immune response to Influenza vaccination. Prevaccination represents the percentage of each group with hemagglutination titers >1:40 to any of the three strains of influenza at baseline. Postvaccination represents a titer of >1:40 or a 4-fold increase in hemagglutination response at 4 weeks after vaccination. 1B: Fold increase in anti-influenza IFN-γ spots by 4 weeks after vaccination (p value among three groups of <0.03 by ANOVA and <0.01 by Wilcoxon sign rank test). 1C: Cellular response to influenza vaccination as measured by ELISPOT over the study period for each group (p value non significant between both vaccinated subgroups for any time point).